Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Different Dynamics for IgG and IgA Memory B Cells in Adolescents following a Meningococcal Serogroup C Tetanus Toxoid Conjugate Booster Vaccination Nine Years after Priming: A Role for Priming Age?
Stoof SP, Buisman AM, van Rooijen DM, Boonacker R, van der Klis FR, Sanders EA, Berbers GA. Stoof SP, et al. Among authors: van rooijen dm, van der klis fr. PLoS One. 2015 Oct 12;10(10):e0138665. doi: 10.1371/journal.pone.0138665. eCollection 2015. PLoS One. 2015. PMID: 26458006 Free PMC article.
Long-term persistence of protective antibodies in Dutch adolescents following a meningococcal serogroup C tetanus booster vaccination.
van Ravenhorst MB, Marinovic AB, van der Klis FR, van Rooijen DM, van Maurik M, Stoof SP, Sanders EA, Berbers GA. van Ravenhorst MB, et al. Among authors: van rooijen dm, van der klis fr, van maurik m. Vaccine. 2016 Dec 7;34(50):6309-6315. doi: 10.1016/j.vaccine.2016.10.049. Epub 2016 Nov 4. Vaccine. 2016. PMID: 27817957
Meningococcal serogroup C immunogenicity, antibody persistence and memory B-cells induced by the monovalent meningococcal serogroup C versus quadrivalent meningococcal serogroup ACWY conjugate booster vaccine: A randomized controlled trial.
van Ravenhorst MB, van der Klis FRM, van Rooijen DM, Knol MJ, Stoof SP, Sanders EAM, Berbers GAM. van Ravenhorst MB, et al. Among authors: van rooijen dm. Vaccine. 2017 Aug 24;35(36):4745-4752. doi: 10.1016/j.vaccine.2017.06.053. Epub 2017 Jun 28. Vaccine. 2017. PMID: 28668575 Clinical Trial.
Seroprevalence and placental transportation of maternal antibodies specific for Neisseria meningitidis serogroup C, Haemophilus influenzae type B, diphtheria, tetanus, and pertussis.
de Voer RM, van der Klis FR, Nooitgedagt JE, Versteegh FG, van Huisseling JC, van Rooijen DM, Sanders EA, Berbers GA. de Voer RM, et al. Among authors: van huisseling jc, van rooijen dm, van der klis fr. Clin Infect Dis. 2009 Jul 1;49(1):58-64. doi: 10.1086/599347. Clin Infect Dis. 2009. PMID: 19480581
Salivary antibody levels in adolescents in response to a meningococcal serogroup C conjugate booster vaccination nine years after priming: systemically induced local immunity and saliva as potential surveillance tool.
Stoof SP, van der Klis FR, van Rooijen DM, Bogaert D, Trzciński K, Sanders EA, Berbers GA. Stoof SP, et al. Among authors: van rooijen dm, van der klis fr. Vaccine. 2015 Jul 31;33(32):3933-9. doi: 10.1016/j.vaccine.2015.06.055. Epub 2015 Jun 19. Vaccine. 2015. PMID: 26100925
Kinetics of Meningococcal Serogroup C-Specific Functional Antibody Levels Up to 15 Years after a Single Immunization with a Meningococcal Serogroup C Conjugate Vaccine during Adolescence.
Stoof SP, van Ravenhorst MB, van Rooijen DM, de Voer RM, van der Klis FRM, Boland GJ, Sanders EAM, Berbers GAM, Teunis PF. Stoof SP, et al. Among authors: van rooijen dm. Clin Vaccine Immunol. 2017 Feb 6;24(2):e00429-16. doi: 10.1128/CVI.00429-16. Print 2017 Feb. Clin Vaccine Immunol. 2017. PMID: 27881489 Free PMC article.
18 results